EZZ Life Science signs $21m distribution deal for South-East Asia with ROFA Enterprises

EZZ Life Science Holdings (ASX: EZZ) has engaged Australian-owned company ROFA Enterprises to distribute a minimum of $21 million in EZZ-branded products across three key markets in South-East Asia.

The three-year non-exclusive agreement commenced this month and allows ROFA to sell the products across Thailand, Vietnam and Singapore.

EZZ sees South-East Asia offering significant commercial upside and long-term growth potential due to the region’s rising health consciousness, expanding middle-class populations and increasing demand for high-quality genomic wellness and functional health products.

Shared responsibilities

Under the terms of the agreement, ROFA will incur all marketing, distribution and logistics costs over the three-year period.

EZZ will retain full control over brand, advertising, product integrity and positioning decisions, as well as ensure compliance with its high standards of product storage, marketing and distribution.

ROFA is prohibited from distributing competing products for the duration of the agreement and for two years thereafter.

Regional growth

EZZ chair Glenn Cross said the new partnership aligned with the company’s strategy to accelerate growth in one of the fastest-growing regions for consumer health and wellness.

“This is a major milestone in our regional expansion strategy,” he said.

“ROFA’s established presence and deep experience in South-East Asia make it an ideal partner to help scale our brand footprint across these important markets and we look forward to building a strong and successful partnership.”

Premium goods exporter

ROFA specialises in the export of premium Australian and New Zealand dairy, health and beauty products to South-East Asia.

The company has built a robust omnichannel distribution network across Vietnam, Thailand and Cambodia that reaches more than 10,000 pharmacies, mother-and-baby stores, supermarkets and online platforms.

ROFA has multiple partnerships with trusted global brands and is committed to delivering tailored marketing support and deep retail expertise to drive brand growth across the region.

US manufacturing deal

EZZ recently made moves to establish a US manufacturing base when it locked in a deal with GLSP Inc to produce a range of EZZ-branded nutrition supplements for the North American market.

The strategic agreement should enhance production efficiencies, improve supply chain logistics and strengthen the company’s regional market positioning.

It stipulates that all products be manufactured to the highest industry standards and meet strict quality control measures including third-party laboratory testing for microbiological and heavy metal analysis for compliance with international safety standards.

“By manufacturing in the US, we enhance our ability to serve the region’s customers with greater speed and efficiency while maintaining our commitment to premium quality and innovation,” Mr Cross said.